Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

...

...

  •  Add new example in to IG 4.0 - Multi-target Microbial Testing Model
  •  Remove MBRESCAT variable from domain spec: SDS-2536
    •  Have never seen use-cases for MBRESCAT, need to consult team on whether this variable has ever been used? If no good use, remove from spec.
      •  Merck: MBRESCAT is used for contaminate, infecting, colonizer and normal flora. There is an example is 3.2 and assumption 6.
      •  Keep MBRESCAT in MB SPEC, no changes needed.
  •  Update MB assumptions, and have team review the updates: 
    •  For typically direct antimicrobial assessments, see PPT to FDA. (tick)
    •  Add text on multiple target test. (tick)
    •  Update 1b and add 1c to describe how to model semi open-ended question as shown in example 5 and COVID-19 V2 TAUG - SDTM. Virus Identification 2(tick) 

...

  •  Remove the MSRESCAT variable, this should have been done since IGv3.2. If not used for anything else (ask team), then this should be deprecated.
    •  Controlled Terminology - Create MSSTRESC codelist? I created a codelist for team to review (tick) 
      •  For this one, the results are unique to MS, so a single, unified lab-based STRESC codelist probably does not apply here?
      •  Make sure to also look at request to remove MBRESCAT.
    •  Related JIRA issues: SDS-2536; SDS-2534
    •  MSRESCAT has been removed from the MS Spec Table
  •  Decisions: 1. removing MSRESCAT from Spec, but people can use it because it is a permissible variable for findings domain. 2. OK with deprecating the MSRESCAT CT codelist. 3. we will discuss where to move the existing MSRESCAT terminology. 4 check with Kathleen for removing MSRESCAT.

...